Pielotax Protocol
Dosing & Research
Last Updated: April 22, 2026
Renal support research, Kidney aging models, Tubular-cell resilience, Urinary-system recovery
Half-Life
Not Well Characterized
Administration
Oral
Frequency
Daily
How It Works
- Renal support research
- Kidney aging models
- Tubular-cell resilience
- Urinary-system recovery
Dosing Structure
Dose
20–40 mg
Frequency
Daily
Notes
Typically Administered As Defined Courses (10–20 Days) Repeated 1–2x Per Year
Example Protocols
Dose: 20–40 mg
Frequency: Daily
Duration: 10-30 days
Off Period: Not listed
Protocol Notes
•
Typically administered as defined courses (10–20 days) repeated 1–2x per year.
Research & Studies
Loading citations…
Research Feedback
0 approved
For research discussion only. Community feedback is moderated and shown here as aggregated insights after approval.
Be the first to submit research feedback for this peptide.
Approved submissions will appear here as aggregated insights.